Immunome (IMNM) Return on Sales [ROS] (2020 - 2026)
Immunome (IMNM) reported Return on Sales [ROS] of -5947.90% for Q1 2026, down 4422.40 percentage points from -1525.50% a year earlier and down 2719.07 percentage points from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
For FY2025, Immunome posted Return on Sales [ROS] of -3228.83%, up 153.54 percentage points from FY2024.
- By year, Return on Sales [ROS] came in at -3382.37% in FY2024 (-2601.02 pp) and -781.35% in FY2023.
- The Q1 2026 figure ranks as the lowest quarterly Return on Sales [ROS] since Q1 2024.
- Year over year, Return on Sales [ROS] has now declined in each of the last three quarters, with an average year-over-year change of +355.27 percentage points over the last eight quarters.
- The high point for year-over-year Return on Sales [ROS] in five years was Q1 2025 (a gain of 11331.55 percentage points); the low point was Q1 2024 (a drop of 12667.92 percentage points).
- Per Business Quant data, the three quarters before Q1 2026 came in at -3228.83% (Q4 2025), -2419.90% (Q3 2025) and -1157.61% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 28.37% |
| 10 | Immunome | 2.04 Bn | 11.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -5,947.90% |
| Dec 31, 2025 | -3,228.83% |
| Sep 30, 2025 | -2,419.90% |
| Jun 30, 2025 | -1,157.61% |
| Mar 31, 2025 | -1,525.50% |
| Dec 31, 2024 | -3,030.31% |
| Sep 30, 2024 | -1,736.15% |
| Jun 30, 2024 | -1,692.43% |
| Mar 31, 2024 | -12,857.05% |
| Dec 31, 2023 | -2,473.94% |
| Sep 30, 2023 | -129.96% |
| Jun 30, 2023 | -135.42% |
| Mar 31, 2023 | -189.13% |
| Dec 31, 2022 | -778,700.00% |
| Sep 30, 2022 | -853,400.00% |
| Jun 30, 2022 | -446,300.00% |
| Mar 31, 2022 | -1,165,400.00% |
| Jun 30, 2020 | -54,300.00% |
API Access
Immunome Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();